Second-generation BRAF inhibitor Encorafenib resistance is regulated by NCOA4-mediated iron trafficking in the drug-resistant malignant melanoma cells

在耐药性恶性黑色素瘤细胞中，第二代BRAF抑制剂恩科拉非尼的耐药性受NCOA4介导的铁转运调控。